Clinical Translation of Cancer Nanotechnology
Director, Nanotechnology for Cancer Programs, NCI Alliance for Nanotechnology in Cancer, National Institutes of Health (NIH)
Dr. Piotr Grodzinski is a Director of Nanotechnology for Cancer programs at Nanotechnology Alliance of National Cancer Institute in Bethesda, Maryland. He is an internationally recognized authority in the areas of bio- and nano-chip assays and microfluidics. Prior to joining NCI, he was with the Bioscience Division of Los Alamos National Laboratory where he served as a Group Leader and an interim Chief Scientist for DOE Center for Integrated Nanotechnologies (CINT). He also held research management positions at Motorola where he directed the Microfluidics Laboratory at Physical Sciences Research Laboratories in Tempe, AZ. His work there focused on the development of self-contained microfluidic cartridges for sample-to-answer genetic assays with an integrated sample preparation, on-chip fluid transport, and detection using DNA hybridization sensors.
Dr. Grodzinski received a Ph.D. in Materials Science from the University of Southern California, Los Angeles in 1992. He has 12 patents awarded and 10 disclosures pending. He co-authored over 100 technical publications and conference presentations. Dr. Grodzinski has been an invited speaker and served on the committees of numerous bio- and nano-MEMS conferences in the past years.
Speaking in the symposiums on Nanotechnology for Cancer Prevention, Diagnosis and Treatment, Nano Medicine and Drug Delivery